NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹116 Cr | ₹126 Cr | ₹104 Cr | ₹108 Cr | ₹83 Cr |
What is the latest Net Current Assets ratio of NGL FINECHEM ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹116 Cr |
Mar2024 | ₹126 Cr |
Mar2023 | ₹104 Cr |
Mar2022 | ₹108 Cr |
Mar2021 | ₹83 Cr |
How is Net Current Assets of NGL FINECHEM Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹116 Cr | -7.67 | |
Mar2024 | ₹126 Cr | 20.81 | |
Mar2023 | ₹104 Cr | -3.22 | |
Mar2022 | ₹108 Cr | 30.30 | |
Mar2021 | ₹83 Cr | - |
Compare Net Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹916.1 Cr | 11.9% | 12.8% | -40.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 11.9% |
12.8% |
-40.5% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses